1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > Kidney Transplantation-Pipeline Insights, 2017


DelveInsight’s, “ Kidney Transplantation-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Kidney Transplantation. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Kidney Transplantation. DelveInsight’s Report also assesses the Kidney Transplantation therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope

- The report provides competitivepipeline landscape of Kidney Transplantation
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Kidney Transplantation pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Kidney Transplantation and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Kidney Transplantation-Pipeline Insights, 2017
Illustrative

- Kidney Transplantation Overview
- Kidney Transplantation Pipeline Therapeutics
- Kidney Transplantation Therapeutics under Development by Companies
- Kidney Transplantation Filed and Phase III Products
- Comparative Analysis
- Kidney Transplantation Phase II Products
- Comparative Analysis
- Kidney Transplantation Phase I and IND Filed Products
- Comparative Analysis
- Kidney Transplantation Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Kidney Transplantation - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Kidney Transplantation - Discontinued Products
- Kidney Transplantation - Dormant Products
- Companies Involved in Therapeutics Development for Kidney Transplantation
- Appendix
- Methodology
- Contact Us
- Disclaimer


List of Tables

- Number of Products under Development for Kidney Transplantation, 2017
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2017
- Comparative Analysis Phase II Products, 2017
- Comparative Analysis Phase I and IND Filed Products, 2017
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2017
- Drug Candidates Profiles
- Kidney Transplantation Assessment by Monotherapy Products
- Kidney Transplantation Assessment by Combination Products
- Kidney Transplantation Assessment by Route of Administration
- Kidney Transplantation Assessment by Stage and Route of Administration
- Kidney Transplantation Assessment by Molecule Type
- Kidney Transplantation Assessment by Stage and Molecule Type
- Kidney Transplantation Therapeutics - Discontinued Products
- Kidney Transplantation Therapeutics - Dormant Products
- Products under Development by Companies, 2017


List of Figures

- Number of Products under Development for Kidney Transplantation, 2017
- Filed and Phase III Products, 2017
- Phase II Products, 2017
- Phase I and IND Filed Products, 2017
- Discovery and Pre-Clinical Stage Products, 2017
- Kidney Transplantation Assessment by Monotherapy Products
- Kidney Transplantation Assessment by Combination Products
- Kidney Transplantation Assessment by Route of Administration
- Kidney Transplantation Assessment by Stage and Route of Administration
- Kidney Transplantation Assessment by Molecule Type
- Kidney Transplantation Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Transplant Diagnostics: Technologies and Global Markets

Transplant Diagnostics: Technologies and Global Markets

  • $ 6650
  • Industry report
  • October 2016
  • by BCC Research

Use this report to: - Identify key market segments - Gain insight into the trends, gaps, and opportunities in each of the micro markets. - Learn about the key market dynamics and the factors impacting ...

Spinal Implants and Surgical Devices Market by Technology, Product - Global Forecast to 2021

Spinal Implants and Surgical Devices Market by Technology, Product - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The global spinal implants and surgical devices market is estimated to reach 17.27 billion by 2021, at a CAGR of 5.3% from 2016 to 2021. Although mature markets (such as North America and Europe) hold ...

Medical Composites Market by Fiber Type, Application - Global Forecast to 2021

Medical Composites Market by Fiber Type, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

“Medical composites market projected to register a CAGR of 7.10% during forecast period” The medical composites market size is projected to reach USD 934.7 million by 2021, at a CAGR of 7.10% between ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.